The risk of hepatitis B virus reactivation and the role of antiviral prophylaxis in hepatitis B surface antigen negative/hepatitis B core antibody positive patients with diffuse large B-cell lymphoma receiving rituximab-based chemotherapy-Reference-Cited by-同舟云学术

The risk of hepatitis B virus reactivation and the role of antiviral prophylaxis in hepatitis B surface antigen negative/hepatitis B core antibody positive patients with diffuse large B-cell lymphoma receiving rituximab-based chemotherapy

Published:2014-08-19 Issue:4 Volume:56 Page:1027-1032
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Lu Shasha,Xu Yu,Mu Qitian,Cao Lihong,Chen Jian,Zhu Zhijuan,Lou Yinjun,Meng Haitao,Qian Wenbin,Tong Hongyan,Mai Wenyuan,Huang Jian,Yu Wenjuan,Zhao Xiaoying,Jin Jie

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2014.947606

Reference28 articles.

1. Hepatitis B Virus Infection

2. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

3. Chronic hepatitis B

4. Systematic Review: The Effect of Preventive Lamivudine on Hepatitis B Reactivation during Chemotherapy

5. Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of hepatitis B surface and core antibody levels on hepatitis B virus reactivation;2023-10-23

2. HBsAg (−)/HBsAb (−)/HBeAg (−)/HBeAb (+)/HBcAb (+) predicts a high risk of hepatitis B reactivation in patients with B‐cell lymphoma receiving rituximab based immunochemotherapy;Journal of Medical Virology;2023-02

3. Clinical and economic evaluation of a surveillance protocol to manage hepatitis B virus (HBV) reactivation among lymphoma patients with resolved HBV infection receiving rituximab;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2021-02-27

4. The association of hepatitis B virus screening and antiviral prophylaxis with adverse liver outcomes in Chinese cancer patients undergoing chemotherapy;Medicine;2020-04

5. Prevention of hepatitis B virus reactivation in patients with hematological malignancies and resolved hepatitis B virus infection: a systematic review and meta‐analysis;Journal of Digestive Diseases;2020-03